Skip to main content
. Author manuscript; available in PMC: 2019 Apr 5.
Published in final edited form as: Expert Opin Drug Discov. 2018 Oct 29;13(11):1055–1065. doi: 10.1080/17460441.2018.1538207

Figure 3:

Figure 3:

GaMD simulations revealed pathways of dissociation and binding of the arecoline (ARC) partial agonist in the M2 muscarinic GPCR: (A) timecourse of the distance between ARC and residue Asp1033.32 of the M2 receptor during 2030 ns GaMD simulation. Four dissociation and three binding events are labeled. (B–H) Schematic representations of the ligand pathways during (B) “D1,” (C) “B1,” (D) “B2,” (E) “B3,” (F) “D2,” (G) “D3,” and (H) “D4.” The receptor is represented by blue ribbons and the ligand by sticks colored by the position along the membrane normal. (I) Ten lowest energy structural clusters of ARC that are labeled and colored in a GWR scale according to the PMF values. Adapted with permission from Y. Miao, J.A. McCammon, Graded activation and Free Energy Landscapes of a Muscarinic G-Protein-Coupled Receptor. Proc. Natl. Acad. Sci. U. S. A. 2016, 113(43), 12162–12167.